In much the same way that each of our bodies depends on bones for mechanical integrity and strength, each cell within our bodies is governed mechanically by a skeleton of composite materials including protein polymers (such as actin filaments) and motor proteins (myosin), called the cytoskeleton. Actin and myosin are key components in muscle contraction and cell motility. The cytoskeleton is an active material that maintains cell shape, enables some cell motion, and plays important roles in both intra-cellular transport and cellular division. The cytoskeletal system is not at thermodynamic equilibrium and this non-equilibrium drives motor proteins that are the force generators in cells. Analogous to how our bones are held and moved by muscles, the cytoskeleton is activated by these molecular motors, which are nanometer-sized force-generating enzymes. In an ongoing effort to design and create a simplified, bottom-up model of the cytoskeleton, researchers now have designed and assembled a biomolecular model system capable of mechanical activity similar to that of living cells. This work could serve as a starting point for exploring both model systems and cells in quantitative detail, with the aim of uncovering the physical principles underlying the active regulation of the complex mechanical functions of cells. It could also provide new fundamental insights and offer new design principles for materials science.

Nanotechnology-enabled tissue engineering is receiving increasing attention. The ultimate goal of tissue engineering as a medical treatment concept is to replace or restore the anatomic structure and function of damaged, injured, or missing tissue. At the core of tissue engineering is the construction of three-dimensional scaffolds out of biomaterials to provide mechanical support and guide cell growth into new tissues or organs. Biomaterials can be variously permanent or biodegradable, naturally occurring or synthetic, but inevitably need to be biocompatible. Using nanotechnology, biomaterial scaffolds can be manipulated at atomic, molecular, and macromolecular levels. Creating tissue engineering scaffolds in nanoscale also may bring unpredictable new properties to the material, such as mechanical (stronger), physical (lighter and more porous) or chemical reactivity (more active or less corrosive), which are unavailable at micro- or macroscales. For bone tissue engineering, a special subset of osteoinductive, osteoconductive, integrative and mechanically compatible materials are required. Such materials need to provide cell anchorage sites, mechanical stability, structural guidance and an in vivo milieu. Moreover, they need to provide an interface able to respond to local physiological and biological changes and to remodel the extracellular matrix (ECM) in order to integrate with the surrounding native tissue. Scientists in Singapore have developed a new nanoscale biocomposite that brings researchers one step closer to mimicking the architecture of the ECM.

Hyperthermia therapy, a form of cancer treatment with elevated temperature in the range of 41-45C, has been recently paid considerable attention because it is expected to significantly reduce clinical side effects compared to chemotherapy and radiotherapy and can be effectively used for killing localized or deeply seated cancer tumors. Accordingly, various forms of hyperthermia have been intensively developed for the past few decades to provide cancer clinics with more effective and advanced cancer therapy techniques. However, in spite of the enormous efforts, all the hyperthermia techniques introduced so far were found to be not effective for completely treating cancer tumors. The low heating temperature owing to the heat loss through a relatively big space gap formed between targeted cells and hyperthermia agents caused by the hard to control agent transport, as well as killing healthy cells attributed to the difficulties of cell differentiations by hyperthermia agents, are considered as the main responsibilities for the undesirable achievements. In a possible breakthrough, researchers in Singapore now report the very promising and successful self-heating temperature rising characteristics of NiFe2O4 nanoparticles. Different from conventional magnetic hyperthermia, in-vivo magnetic nanoparticle hyperthermia is expected to be one of the best solutions for killing tumor cells which are deeply seated and localized inside the human body.

Silver has long been recognized for its infection-fighting properties and it has a long and intriguing history as an antibiotic in human health care. In ancient Greece and Rome, silver was used to fight infections and control spoilage. In the late 19th century, the botanist von Naegeli discovered that minute concentrations of silver contained microbiocidal properties. However, as the first antibiotics were discovered, this old household remedy was quickly forgotten. In an alarming trend, bacteria and other microorganisms that cause infections are becoming remarkably resilient and can develop ways to survive drugs meant to kill or weaken them. This antibiotic resistance is due largely to the increasing use of antibiotics. This led researchers to re-evaluate old antimicrobial substances such as silver. Silver nanoparticles have become the promising antimicrobial material in a variety of applications because they can damage bacterial cells by destroying the enzymes that transport cell nutrient and weakening the cell membrane or cell wall and cytoplasm. Unfortunately, in practical applications, the pure silver nanoparticles are unstable with respect to agglomeration. In most cases, this aggregation leads to the loss of the properties associated with the nanoscale of metallic particles. The stabilization of metallic colloids and thus the means to preserve their finely dispersed state is a crucial aspect to consider during their applications. Researchers in China have successfully demonstrated the use of a natural macroporous matrix for fabricating a stable, biocompatible nanocomposite with high silver content for antimicrobial purposes.

Nanosurgery holds the promise of studying or manipulating and repairing individual cells without damaging the cell. For instance, nanosurgery could remove or replace certain sections of a damaged gene inside a chromosome; sever axons to study the growth of nerve cells; or destroying an individual cell without affecting the neighboring cells. While the cell nucleus has been transplanted between cells during cloning using micropipette technologies, these methods are too crude for other subcellular structures. First steps towards nanosurgery have been made using so-called 'optical tweezers', where the energy of laser light is used to trap and manipulate nanoscale objects, for instance the nucleus of a cell, without mechanical contact. Combined with a laser scalpel (use of lasers for cutting and ablating biological objects) optical tweezers have been used to study cell fusion, DNA-cutting, etc. Unfortunately, while optical tweezers offer exquisite sensitivity in their ability to position micro- and nanoparticles, they suffer from one important disadvantage: the trapped particle is localized at the laser focus where light intensity is the highest. As a result, the laser light used to trap a particle also has a propensity to photobleach and photodamage the particle, especially when the particle is fragile and small (e.g., a subcellular organelle that is fluorescently labeled). Minimizing this drawback, new research describes the use of polarization-shaped optical vortex traps for the manipulation of particles and subcellular structures.

As the most common endocrine metabolic disorder for human beings, diabetes mellitus with an obvious phenomenon of high blood glucose concentrations results from a lack of insulin. Despite the availability of treatment, diabetes has remained a major cause of death and serious vascular and neuropathy diseases. Continuously monitoring the blood glucose level and intermittent injections of insulin are widely used for effective control and management of diabetes. Extensive research has been conducted to develop optimal glucose sensors for diagnostic purposes. Currently, the commercially available glucose biosensors still have some problems to overcome, such as time consuming, relatively low sensitivity, bad reliability. The performance of a glucose sensor is largely dependent upon the materials which construct the sensor. Recent research effort for glucose sensing have turned to on nanomaterials. Nanomaterial-based biosensors already have shown the capability of detecting trace amounts of biomolecules in real time. New research has studied the electrochemical characteristics of platinum decorated carbon nanotubes (CNTs) as a promising candidate for glucose sensing. Its improved performance may encourage further exploration of this novel nanomaterial in the field of bioapplications.

Thermolysis (from thermo- meaning heat and -lysis meaning break down) is a chemical process by which a substance is decomposed into other substances by use of heat. In photothermolysis the transfer of laser energy is used to generate the required heat. And finally, nanophotothermolysis is the process where nanoparticles, when irradiated by short laser pulses, get hot so quickly that they explode. This thermal explosion of nanoparticles (nanobombs) may be accompanied by optical plasma, generation of shock waves with supersonic expansion and particle fragmentation with fragments of high kinetic energy, all of which can contribute to the killing of cancer cells they are attached to. By engineering the laser wavelength, pulse duration and particle size and shape, this technology can provide highly localized damage in a controlled manner, potentially varying from a few nanometers (for DNA) to tens of microns (the size of a single cancer cell) without damaging the surrounding tissue.

If you had brain tumor, would you rather receive your medicine through an injection in the arm or have a hole drilled in your skull? Even if you opted for the 'hole-in-the-skull' method, brain cancers are often inoperable due to their location within critical brain regions or because they are too small to detect. Nanotechnology offers a vision for a 'smart' drug approach to fighting tumors: the ability of nanoparticles to locate cancer cells and destroy them with single-cell precision. One of the most important applications for such nanoparticulate drug delivery could be the delivery of the drug payload into the brain. However, crossing the brains protective shield, the blood-brain barrier, is a considerable challenge. Novel targeted nanoparticulate drug delivery systems that are able to cross this barrier bring us closer to this vision of brain cancer destroying drugs.